Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 215,000 | 378,000 | 593,000 | 1M | 2M | 1M |
| Research and development | 19M | 19M | 20M | 16M | 18M | 15M |
| Selling, general and administrative | 9M | 8M | 9M | 9M | 9M | 9M |
| Operating expenses | 31M | 31M | 32M | 29M | 31M | 28M |
| Operating income | −31M | −30M | −31M | −28M | −29M | −27M |
| Pre-tax income | −30M | −29M | −30M | −26M | −27M | −25M |
| Income tax | 18,000 | 104,000 | 131,000 | −4,000 | 37,000 | 0 |
| Net income | −30M | −29M | −31M | −26M | −27M | −25M |
| Earnings per share | −0.19 | −0.20 | −0.24 | −0.21 | −0.24 | −0.22 |
| Earnings per share, diluted | −0.19 | −0.20 | −0.24 | −0.21 | −0.24 | −0.22 |
| Weighted average shares | 153M | 144M | 128M | 124M | 114M | 113M |
| Weighted average shares, diluted | 153M | 144M | 128M | 124M | 114M | 113M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 9M | 20M | 9M | 38M | 47M | 41M | 55M | 61M |
| Short-term investments | 117M | 124M | 143M |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | −26M | — | — | −22M | — | — |
| Depreciation and amortisation | 3M | 3M | 3M | 3M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| — |
| — |
| 71M |
| — |
| — |
| Receivables | — | — | 1M | 700,000 | 1M | 0 | — | — |
| Current assets | 132M | 150M | 175M | 137M | 156M | 134M | 150M | 165M |
| Total assets | 196M | 216M | 245M | 210M | 232M | 214M | 235M | 256M |
| Current liabilities | 20M | 23M | 30M | 31M | 27M | 29M | 27M | 25M |
| Total liabilities | 24M | 27M | 35M | 37M | 34M | 34M | 34M | 34M |
| Equity | 172M | 189M | 210M | 173M | 199M | 179M | 201M | 221M |
| Shares outstanding | — | — | — | — | — | 115M | 114M | 113M |
| Shares issued | — | — | — | — | — | 115M | 114M | 113M |
| 3M |
| 3M |
| Share-based compensation | 4M | — | — | 5M | — | — |
| Capital expenditure | 30,000 | — | — | 25,000 | — | — |
| Investing cash flow | 7M | — | — | −15M | — | — |
| Financing cash flow | 8M | — | — | 43M | — | — |